Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,271 | 0 | 0 | 14,068 | 36,984 |
| Gross Profit | 2,271 | N/A | N/A | 14,068 | 36,984 |
| Operating Expenses | 94,181 | 84,534 | 58,998 | 98,099 | 64,534 |
| Operating Income | -91,910 | -84,534 | -58,998 | -84,031 | -27,550 |
| Interest Expense | 0 | 0 | 0 | 764 | 0 |
| Other Income | 8,470 | 3,389 | 976 | 124 | 1,074 |
| Pre-tax Income | -83,440 | -81,145 | -58,022 | -84,671 | -26,476 |
| Income Tax | 141 | 27 | 10 | 15 | 35 |
| Net Income Continuous | -83,581 | -81,172 | -58,032 | -84,686 | -26,511 |
| Net Income | $-83,581 | $-81,172 | $-58,032 | $-84,686 | $-26,511 |
| EPS Basic Total Ops | -9.37 | -53.08 | -227.42 | -123.50 | -41.00 |
| EPS Basic Continuous Ops | -9.37 | -53.09 | -227.58 | -123.27 | -41.10 |
| EPS Diluted Total Ops | -9.37 | -53.08 | -227.42 | -123.50 | -41.00 |
| EPS Diluted Continuous Ops | -9.37 | -53.09 | -227.58 | -123.27 | -41.10 |
| EPS Diluted Before Non-Recurring Items | -9.37 | -53.08 | -116.50 | -123.50 | -41.00 |
| EBITDA(a) | $-90,127 | $-80,984 | $-56,632 | $-81,256 | $-26,404 |